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Abstract
Background: Dendritic cells (DCs) are the highly specialized antigen presenting cells of the immune system that
play a key role in regulating immune responses. DCs can efficiently initiate immune responses or induce tolerance.
Due to this dual function, DCs are studied in the context of immunotherapy for both cancer and autoimmune
diseases. Characterization of DC-specific genes, leading to better understanding of DC immunobiology, will help to
guide their use in clinical settings. We previously identified DC-STAMP, a multi-membrane spanning protein
preferentially expressed by DCs. DC-STAMP resides in the endoplasmic reticulum (ER) of immature DCs and
translocates towards the Golgi compartment upon maturation. In this study we knocked down DC-STAMP in
mouse bone marrow-derived DCs (mBMDCs) to determine its function.
Results: We demonstrate that DC-STAMP knock-down mBMDCs secrete less IL-6, IL-12, TNF-a and IL-10 while IL-1
production is enhanced. Moreover, LPS-matured DC-STAMP knock-down mBMDCs show impaired T cell activation
potential and induction of Th1 responses in an alloreaction.
Conclusions: We show that DC-STAMP plays an important role in cytokine production by mBMDCs following LPS
exposure. Our results reveal a novel function of DC-STAMP in regulating DC-initiated immune responses.
Background
Dendritic cells (DCs) are professional antigen presenting
cells (APC) that play a central role in innate and adap-
tive immunity. DCs, armed with a wide range of recep-
tors that sense danger signals and scavenge antigens in
the surrounding environment, constantly scan our body.
Antigen uptake in the presence of inflammation and
danger signals results in DC maturation. In this active
state DCs are able to efficiently induce immune
responses [1]. On the other hand, in the absence of dan-
ger signals DCs regulate tolerance to self-antigens in
order to prevent autoimmunity.
During maturation DCs upregulate costimulatory
molecules such as CD40, CD80 and CD86 as well as
MHC class II, which allows for effective antigen
presentation to naïve T cells. Furthermore, mature DCs
produce and secrete proinflammatory cytokines and
chemokines to attract and activate innate effector cells
as well as to direct the development of specific T helper
(Th) subsets [2]. High levels of IL-12 will induce differ-
entiation of naïve CD4+ T cells into Th1 cells while
blocking the development of the Th2 lineage [3]. To
prime Th2 responses IL-4 produced by Th2 cells them-
selves, NKT cells, eosinophils or basophils is needed
[4,5]. Additionally, IL-1 has a positive influence on
expansion of the murine Th2 cells [6]. The murine
Th17 T-cell subset efficiently develops in the presence
of the proinflammatory cytokines IL-6 and TGF-b [7].
Due to their immunoregulatory capacities DCs are a
promising tool for immunotherapy. Indeed, DC-based
therapies are currently being used for treatment of can-
cer, autoimmune diseases and the prevention of trans-
plant rejection [8-12]. Detailed understanding of
molecular aspects of DC immunobiology is crucial for
optimal application of DCs in immunotherapy.
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Characterization of genes like DC-SIGN [13], DC-CK1
[14] and DC-SCRIPT [15-17] has already resulted in
many novel findings regarding the molecular basis of
DC function.
Recently, we reported on the isolation and characteri-
zation of a novel molecule named DC-STAMP, both in
human and mouse DCs [18,19]. DC-STAMP was shown
to be a multi-membrane spanning protein preferentially
expressed by myeloid DCs [18], macrophages [20] and
osteoclasts [21]. In immature DCs, DC-STAMP localizes
to the endoplasmic reticulum [22] and upon DC
maturation translocates towards the Golgi compartment,
which is most likely facilitated by its interacting partner
OS9 [23], a protein that has previously been implicated
in ER-to-Golgi transport [24,25]. Interestingly, DC-
STAMP also interacts with the ER-resident transcription
factor LUMAN [26]. LUMAN is activated in a process
called regulated intramembrane proteolysis (RIP), which
involves its translocation to the Golgi compartment,
proteolytic cleavage and subsequent nuclear localization
[27]. The immunological and biological processes DC-
STAMP is involved in are only recently emerging. Func-
tional studies in DC-STAMP knock-out mice have
shown that DC-STAMP is essential for fusion of osteo-
clasts and foreign body giant cells [21,28]. Much less is
known regarding the role of DC-STAMP in myeloid
immune cells. DC-STAMP was shown to inhibit granu-
locyte development from hematopoietic progenitors
cells [29], however its expression is not required for
proliferation and differentiation of DCs [30]. Initial data
using immature DCs from DC-STAMP knock-out mice
have suggested involvement of DC-STAMP in
phagocytosis and antigen presentation. As aged DC-
STAMP knock-out mice show symptoms of autoim-
mune diseases, a role of DC-STAMP in maintaining the
balance between immunity and tolerance has been pro-
posed [30].
In the current study we examined the role of DC-
STAMP in immature and TLR-matured DCs. For this
purpose, we generated lentiviruses encoding DC-
STAMP-specific shRNAs to knock-down DC-STAMP in
BMDCs. We found that DC-STAMP knock-down in
mature but not immature DCs affects cytokine produc-
tion, induction of T cell proliferation and Th1 cell
activation.
Results
DC-STAMP silencing in mouse bone marrow-derived DCs
To investigate the role of DC-STAMP in DCs, we per-
formed DC-STAMP knock-down studies in mBMDCs.
Hereto, four different DC-STAMP shRNA sequences
and a control scrambled shRNA sequence (shScr) were
tested for their ability to silence murine DC-STAMP-
GFP following co-transfection in HEK293 cells. Silen-
cing was assessed by western blot analysis using antibo-
dies directed against the GFP-moiety of the DC-
STAMP-GFP fusion protein (Figure 1A). The results
show that the shRNA sequences shST1 and shST4 were
most effective in DC-STAMP silencing whilst the
scrambled shRNA had no effect. Therefore, these two
DC-STAMP shRNA sequences were chosen for further
use in mBMDCs. As mBMDCs are difficult to transfect,
we used lentiviral shRNA delivery to stably produce
shRNA from an integrated RNAi cassette and avoid as
Figure 1 Efficiency of DC-STAMP silencing. (A) HEK293 cells were co-transfected with mDC-STAMP-GFP plasmid and one of four plasmids
expressing different shRNA sequences, designed to silence DC-STAMP, or with plasmid expressing scrambled shRNA. Cells were lysed 48 hours
post-transfection and lysates were subjected to Western blot analysis. Blots were stained for GFP and re-probed for b-actin as an internal
reference. Data shown are representative of two independent experiments. (B) Murine BMDCs were transduced with lentivirus expressing shST1
or shST4 to silence DC-STAMP, or shScr as a negative control. Messenger RNA expression of DC-STAMP was assessed by qPCR. Levels of
normalized DC-STAMP mRNA expression in cells infected with shST1 and shST4 lentiviruses were related to normalized DC-STAMP mRNA
expression in shScr lentivirus infected cells. Data are depicted as mean percentage of control (shScr) ± SEM of three independent experiments.
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much as possible the host’s defense mechanisms.
Assessment of the effect of lentiviral transduction on
maturation marker expression and cytokine production
at the time of DC stimulation, revealed comparable
levels of CD86 and MHC class II expression between
non-transduced and mock transduced (shScr) mBMDCs.
Additionally, proinflammatory and anti-inflammatory
cytokines were not detectable in the supernatants of
both non-infected and infected cells (data not shown).
Taken together, these results indicate that infected cells
did not mature spontaneously.
Bone marrow-derived DCs were infected with lenti-
virus expressing shST1, shST4 or shScr at day 6 and day
7 of culture. As specific antibodies against mDC-
STAMP are not available, silencing of mDC-STAMP in
mBMDCs was determined at the mRNA level by quanti-
tative real-time PCR (qPCR). Effective silencing of DC-
STAMP mRNA was observed at both day 9 and day 11
of culture (40 and 90 hours after second transduction)
(Figure 1B and data not shown). DCs at day 11 of cul-
ture were used for further experiments. In accordance
with the results in HEK293 cells, shST1 was more effec-
tive in silencing DC-STAMP (70% silencing) as com-
pared to shST4 Collectively, these data show that we are
able to effectively silence DC-STAMP mRNA in
mBMDCs with two independent shRNAs.
DC-STAMP silencing does not induce phenotypic changes
in mBMDCs
First, the effect of DC-STAMP silencing on DC mor-
phology and appearance was determined. Observation of
the cells in culture after infection (day 6 and 7) until
day 11 of culture did not reveal significant differences in
DC morphology of both the non-adherent and loosely
adherent cells between DC-STAMP knock-down and
control cells (Figure 2A). As DC-STAMP is a molecule
residing in the endoplasmic reticulum, we investigated
the ER in DC-STAMP knock-down and control cells in
more detail by staining for the ER-residing protein calre-
ticulin. Confocal microscopy analysis of the ER did not
show any substantial differences in ER abundance or
morphology in the DC-STAMP knock-down cells (Fig-
ure 2B). This confirms results from DC-STAMP defi-
cient mice indicating that DC-STAMP does not affect
the appearance of the ER in DCs [30].
To evaluate the effects of DC-STAMP silencing on the
expression of DC surface molecules flow cytometry ana-
lysis was performed. Expression of MHC class I and
class II, and the costimulatory molecules, CD80, CD86
and CD40 was analyzed on immature and LPS-matured
DC-STAMP knock-down (shST1 and shST4) and con-
trol (shScr) mBMDCs. To monitor the effect of viral
infection, non-infected cells (no virus) were taken along
in this analysis. No significant differences between
control (shScr) and DC-STAMP knock-down immature
mBMDCs were observed for any of the surface markers
analyzed (Figure 2C and data not shown). Upon LPS sti-
mulation for 24 hours, CD80, CD86, and MHC class II
expression levels were elevated in both control and DC-
STAMP-silenced DCs (Figure 2C and data not shown).
Non-infected and control shRNA (shScr) infected
mBMDC did not significantly differ in their response to
LPS stimulation, although the upregulation of costimula-
tory molecules in lentivirus infected cells was somewhat
less. Furthermore, no differences in overall morphology
or cell death were observed between the DC-STAMP
knock-down and control cells following LPS-induced
DC maturation. These data show that the phenotype of
DC-STAMP knock-down cells does not differ from the
control cells and correlates with results obtained from
DC-STAMP knock-out mice [30]. Additionally, our data
show that the upregulation of costimulatory molecules
following maturation is not affected in DC-STAMP
silenced DCs relative to control cells.
LPS-induced cytokine secretion is altered in DC-STAMP
knock-down mBMDCs
Upon DC maturation, along with changes in cell sur-
face molecule expression, DCs also begin secreting
cytokines and chemokines that play an important role
in regulating immune responses. To determine the
capacity of DC-STAMP knock-down mBMDCs to pro-
duce cytokines, cells were either left unstimulated or
stimulated with LPS for 6, 16 and 24 hours and the
production of IL-6 was measured by ELISA. No differ-
ence in the cytokine production by the mBMDCs was
observed without LPS stimulation, indicating that
knock-down of DC-STAMP does not induce sponta-
neous IL-6 production. In contrast, the amount of IL-6
in supernatants of the DC-STAMP knock-down DCs
after LPS stimulation was significantly decreased rela-
tive to control mBMDCs at all time points (Figure 3A).
Moreover, this effect was proportional to the level of
DC-STAMP silencing. Cells transduced with shST1
produced 50% less of IL-6 than control mBMDCs
whilst cells transduced with shST4 produced only 20-
30% less. Next, IL-12 p70 levels were measured in
supernatants of DC-STAMP knock-down and control
DCs. No IL-12 was spontaneously induced in imma-
ture DC-STAMP knock-down DCs (Figure 3B). Inter-
estingly, IL-12 p70 was readily detected at 16 and 24
hours of LPS stimulation, but the levels were signifi-
cantly lower in DC-STAMP knock-down mBMDCs
(shST1) (Figure 3B). The finding that the level of DC-
STAMP down-regulation with the two independent
shST1 and shST4 DC-STAMP shRNAs is proportional
to the decrease in IL-12 production further demon-
strates the relevance of this observation.
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To further define the effect of DC-STAMP on cyto-
kine and chemokine production, supernatants of
immature and 24 hours LPS-matured mBMDCs trans-
duced with shST1 and shScr were analyzed by Milli-
plex bead assay. As expected, the predominantly T cell
derived cytokines IFN-g, IL-2, IL-4, IL-5, IL-9, IL-17,
as well as IL-7 and IL-15 were not present at detect-
able levels in the supernatants of mBMDCs irrespective
of DC-STAMP silencing and LPS stimulation (data not
shown). Expression of the chemokines RANTES, IP-10,
KC, MCP-1, MIP-2 as well as growth factor VEGF was
readily detected upon LPS stimulation but no signifi-
cant differences between shST1 and shScr control cells
were observed (Figure 3C and data not shown). In
contrast, the proinflammatory chemokine MIP-1a was
expressed by both immature and mature DC and was
clearly decreased in the supernatants of both immature
and LPS-matured DC-STAMP knock-down DCs (Fig-
ure 3C). Secretion of TNF-a and the anti-inflammatory
cytokine IL-10 was also significantly decreased in
supernatants of the LPS-matured DC-STAMP knock-
down mBMDCs. On the other hand, LPS induction of
the proinflammatory cytokine IL-1a was significantly
increased in DC-STAMP knock-down mBMDCs rela-
tive to control DCs at the 24 hour time point. IL-1b
levels were also increased in supernatants of mature
DC-STAMP knock-down mBMDCs although the dif-
ference did not reach statistical significance (Figure
3C). Further analysis revealed that the increase in IL-
1a production in LPS-matured DC-STAMP silenced
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Figure 2 DC-STAMP silencing does not induce phenotypic changes in mBMDCs. Murine BMDCs were infected with shScr and shST1
lentivirus at day 6 and day 7 of culture. (A) Light field microscopy image of mBMDCs in culture 4 days post-infection. (B) Lentiviraly transduced
mBMDCs stained with antibody against calreticulin (green) to visualize ER and DAPI staining of nucleus (blue) analyzed by CLSM. (C) Flow
cytometric analysis of CD80, CD86 and MHC class II surface expression in CD11c+ immature (-LPS) and LPS-matured (+LPS) non-infected (no
virus), shScr and shST1 mBMDCs. Isotype controls are indicated by shaded area. Data shown are representative of two or three independent
experiments.
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DCs is not present at earlier time points (6 and 16
hours) (data not shown).
To address whether the observed deregulation in cyto-
kine production can be explained by an effect of DC-
STAMP silencing on cytokine transcription, the levels of
the IL-6, IL-12p40, IL-1a and IL-1b mRNA were
assessed (Figure 3D). Detected differences in mRNA
levels fluctuated between experiments, however the
same tendency was observed. IL-6 and IL-12p40 mRNA
levels were decreased in DC-STAMP knock-down cells
(shST1) (20-75% for IL-6, 20-65% for IL-12p40), while
mRNA of IL-1a and IL-1b levels were increased (25-
48% for IL-1a and 27-35% for IL-1b).
Taken together, these results demonstrate that DC-
STAMP deficiency results in the deregulation of cyto-
kine production by mBMDCs and suggest the
involvement of transcriptional regulation of cytokine
genes in this phenomenon.
DC-STAMP deficiency leads to decreased T-cell
proliferation
Next, we investigated the capacity of immature and
LPS-matured DC-STAMP knock-down and control DCs
to stimulate proliferation of CFSE-labeled allogeneic
splenocytes depleted for B220 positive cells. The prolif-
eration rate of total CD3+ T cells co-cultured with
immature mBMDCs did not differ between DC-STAMP
knock-down and control cells (Figure 4A and 4B). In
contrast, when the LPS-matured DC-STAMP knock-
down mBMDCs were used as stimulators a significantly
decreased proliferation rate of total CD3+ T cells was
observed (Figure 4A and 4B). In line with this finding, a
Figure 3 LPS-induced cytokine secretion is altered in DC-STAMP knock-down mBMDCs. Murine BMDCs transduced with shST1, shST4 or
shScr were stimulated with 1 μg/ml of LPS for 6, 16 and 24 hours. (A) Levels of secreted IL-6 were measured by ELISA. Data are expressed as a
percentage of control (shScr). Mean ± SEM calculated of four independent experiments. Values in all experiments ranged from 5 to 500 ng/ml.
(B) Levels of secreted IL-12 p70 were measured by ELISA. Data shown are representative of three independent experiments and are expressed as
a percentage of control (shScr). Mean ± SEM calculated from triplicates. Values in all experiments ranged from 0.4 to 5 ng/ml. (C) Levels of
secreted cytokines were determined in supernatants 0 and 24 hours after LPS stimulation using Milliplex bead assay. Mean ± SEM calculated
from at least three independent experiments. Two-tailed Student t test was performed in A, B and C (ND-not detectable, *p < 0.05; **p < 0.01;
***p < 0.001). (D) Total RNA was isolated from shScr and shST1 mBMDCs stimulated with LPS. Messenger RNA expression levels of IL-6, IL-12p40,
IL-1a and IL-1b were determined by quantitative RT-PCR where PBGD served as an internal reference. Results shown are representative of at
least three independent experiments. The differences in mRNA levels between shScr and shST1 in all experiments ranged from 20% to 75% for
IL-6, 20-65% for IL-12p40, 25-48% for IL-1a and 27-35% for IL-1b.
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significantly higher expression of CD62L was still present
on CD4+ as well as CD8+ T cells in the cultures stimu-
lated with the matured DC-STAMP knock-down
mBMDCs compared to those stimulated with control
DCs (Figure 4C and 4D). No difference in CD62L expres-
sion was observed on the T cells activated by the imma-
ture mBMDCs. These data confirm that DC-STAMP
knock-down mature mBMDCs have an impaired ability
to activate T cells in an allogeneic MLR.
T cells stimulated by activated DCs can differentiate
into different directions to promote Th1, Th2 or Th17
type responses. As we observed differences in prolifera-
tion rate and activation of T cells of co-cultures stimu-
lated with mature mBMDCs, we analyzed supernatants
from these co-cultures for the presence of a number of
cytokines and chemokines (Figure 4E). Strikingly, the
levels of IFN-g, a cytokine produced mainly by CD4+
cells of the Th1 phenotype, were significantly reduced in
supernatants from co-cultures with DC-STAMP knock-
down mature mBMDCs. Cytokines produced by Th2
type cells, IL-4 and IL-5, were present in somewhat
higher amount in supernatants of co-cultures with DC-
STAMP knock-down mBMDCs although these differ-
ences were not statistically significant. No difference in
IL-17 levels was observed in the co-cultures with DC-
STAMP knock-down and control mBMDCs while IL-10
was decreased without reaching statistical significance.
Corresponding to our results obtained from supernatants
of mBMDCs cultures, IL-6 expression was decreased and
IL-1a expression was increased in co-cultures with
mature DC-STAMP knock-down mBMDCs. The proin-
flammatory chemokines MCP-1 and VEGF were present
in significantly higher quantities in supernatants of co-
cultures with DC-STAMP knock-down mBMDCs (Figure
4E) relative to control DC. Together, these results show
that LPS-matured DC-STAMP knock-down mBMDCs
are less efficient in stimulating T cell proliferation and
initiating IFN-g producing Th1 cells.
Figure 4 Decreased ability of DC-STAMP knock-down mBMDCs to stimulate T cell proliferation in allogeneic MLR. Splenocytes depleted
for B220+ cells from Balb/c mice were stained with CFSE and co-cultured with immature (-LPS) or LPS-matured (+LPS) DC-STAMP knock-down
(shST1) or control (shScr) mBMDCs from C57BL/6 mice. (A) FACS data of CFSE dilution in CD3+ T cells. (B) Quantified T-cell proliferation as a
mean fluorescent intensity (MFI) of CFSE dilution in CD3+ T cells. Mean ± SEM of four independent experiments are shown. (C) FACS data of
CD62L surface expression in CD3+CD4+ and CD3+CD8+ T cells (Balb/c) from co-cultures with DC-STAMP knock-down (shST1) or with control
(shScr) mBMDCs (C57BL/6) (black line) compared to isotype control (grey shaded area). Data shown are representative of three independent
experiments. (D) Quantification of CD62L MFI on CD3+CD4+ and CD3+CD8+ T cells (Balb/c) from co-cultures with DC-STAMP knock-down
mBMDCs (shST1) and shScr mBMDCs (C57BL/6). Data are expressed as mean ± SEM of three independent experiments. (E) Supernatants from
allogeneic MLR co-cultures with mature mBMDCs were analyzed for indicated cytokines and chemokines by Milliplex bead assay. Data shown
are mean ± SEM from triplicates and are representative of at least three experiments. Two-tailed Student t test was performed in B, D and E
(ND-not detectable, *p < 0.05; **p < 0.01; ***p < 0.001).
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Discussion
DCs are professional antigen-presenting cells that are
critically involved in the initiation of the primary
immune response [1]. Maturation of the DC is impor-
tant for priming naïve T cells and the generation of
appropriate T cell responses. Here we show that silen-
cing of the DC-expressed molecule DC-STAMP results
in a distorted cytokine production both on mRNA and
protein level in mBMDCs following LPS exposure. The
importance of DC-STAMP in mBMDC maturation is
further emphasized by the decreased ability of mature
but not immature DC-STAMP knock-down DCs to sti-
mulate naïve T cells and to prime Th1 responses.
Studies of DC-STAMP overexpression in murine bone
marrow progenitor cells have suggested that DC-
STAMP affects granulocyte development from hemato-
poietic progenitor cells [29]. On the other hand, analysis
of DC-STAMP knock-out mice mBMDCs shows that
DC-STAMP is not necessary for DC proliferation and
differentiation [30]. Little is known about the role of
DC-STAMP in the maturation of DCs. DC maturation
is a key checkpoint in the initiation of immunity and
has important consequences on the quality of the
immune response. Our previous studies have shown
translocation of DC-STAMP from ER towards the Golgi
compartment upon maturation of DCs [23]. This differ-
ential localization of DC-STAMP in immature and
mature DCs may suggest that DC-STAMP exerts an
important role during the complex process of matura-
tion. No significant differences in the morphology and
the expression of DC-maturation markers between DC-
STAMP knock-down and control immature and mature
mBMDCs was observed. These data indicate that DC-
STAMP silencing does not affect the phenotype of
mBMDCs.
Upon TLR ligation, besides co-stimulatory molecule
expression, DCs also start to produce a wide range of
cytokines and chemokines to attract and stimulate other
cells of the immune system [1]. Our data show that
despite the mature cell surface phenotype, DC-STAMP
knock-down mBMDCs exhibit distorted cytokine pro-
duction upon LPS stimulation (Figure 3). Further analy-
sis indicated that observed differences in secretion of IL-
6, IL-12, IL-1a and IL-1b proteins are accompanied by
the corresponding changes in mRNA levels (Figure 3D),
suggesting regulation at the transcriptional level. Inter-
estingly, one of the DC-STAMP interacting partners,
LUMAN, is a transcription factor that resides in the ER.
For its activation LUMAN is translocated towards the
Golgi compartment, cleaved and subsequently accumu-
lates in the nucleus [27]. Previously, we have shown that
LUMAN protein in human myeloid DCs becomes trans-
located to the nucleus following TLR4 ligation in
mature DCs [26]. Others have shown that LUMAN can
bind to cAMP response element (CRE) and unfolded
protein response element (UPRE) transcription factor
binding sites in promoters of target genes [31-33]. CRE
sites are present in promoters of many cytokines,
including, IL-2, IL-6, IL-10 and TNF-a [34]. It is there-
fore tempting to speculate that LUMAN is responsible
at least in part for the deregulation of cytokine produc-
tion observed in TLR-matured DC-STAMP knock-down
DCs. LUMAN knock-down studies are required to con-
firm this hypothesis.
We further observed that levels of IL-1a and IL-1b
were increased in DC-STAMP knock-down mBMDCs.
This upregulation of IL-1 family cytokines seems to be
contradictory to the observed decrease in IL-6 produc-
tion as it is well established that IL-1 is able to induce
expression of IL-6 [35,36]. The fact that IL-6 is also
implicated in inhibition of IL-1 and TNF-a production
[37,38], however, indicates that the relation between IL-
6 and IL-1a and IL-1b is more complex. Looking at the
mRNA level, IL-6 and IL-1 mRNA production is pri-
marily affected by decreased DC-STAMP expression at
early time points. The decrease in IL-6 protein level was
observed early on after LPS stimulation, while transla-
tion and release of IL-1a and IL-1b took much longer.
These data suggest that the cytokine profile in DC-
STAMP KO DC may be explained by differences in the
kinetics in the transcription, translation and release of
IL-6 and IL-1 cytokines, and could possibly occur
through the involvement of caspase-1/calpain in IL-1b/
IL-1a release [39,40].
Many factors influence the differentiation process of
CD4+ T cells into Th1, Th2 or Th17 effector cells,
including antigen dose, the signal strength through the
T cell receptor, and costimulation [41]. Especially cyto-
kines were shown to be key determinants in the out-
come of this differentiation [2-7]. In our MLR assays we
observed negative effect of DC-STAMP silencing on T
cell activation by mature DCs. Decreased levels of IFN-g
in these co-cultures, indicate an impaired ability of
mature DC-STAMP knock-down mBMDCs to prime
Th1 responses. As IL-12 is critically involved in the pro-
motion of Th1 development [3], we postulate that this
decreased ability to support the development of Th1
lineage is determined by the reduced production of IL-
12 by LPS-stimulated DC-STAMP knock-down
mBMDCs. This is also supported by the fact that
expression of costimulatory molecules was not affected
by DC-STAMP knock-down. Impaired stimulation of
Th1 responses allows differentiation of Th2 and Th17
subsets. Additionally, IL-1a and IL-1b were shown to
stimulate Th2 and Th17 responses [6], as well as induce
the release of Th2 cytokines [42]. The observed increase
in IL-4 and IL-5 levels in co-cultures with mature DC-
STAMP knock-down mBMDCs could suggest skewing
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the responses towards Th2 cells, which may be
enhanced due to the higher levels of IL-1 cytokines in
these co-cultures. Lower number of CD8+ T cells alone
was observed after co-culture with DC-STAMP knock-
down mature mBMDCs, however cells, which were
dividing, went through the same number of divisions
like the ones in co-culture with control mBMDC (data
not shown). We postulate that the decrease in the CD8+
T cells proliferation is a result of the reduced CD4+ T
cells help.
Sawatani et al. showed that aged DC-STAMP knock-
out mice have symptoms of autoimmune disease and
suggested involvement of increased phagocytosis and
antigen presentation in onset of autoimmunity [30]. We
did not observe any differences in T cell proliferation
between control and DC-STAMP knock-down cells
when we used immature DC. This discrepancy between
our and Sawatani et al. data may be explained by differ-
ent design of the proliferation assays. We used allogeneic
MLR to look at the ability of the DC-STAMP knock-
down mBMDCs to stimulate differentiation of naïve T
cells while they looked at antigen-specific (OVA)
responses. Decreased levels of proinflammatory cytokines
IL-6, IL-12 and TNF-a do not easily explain the symp-
toms of autoimmune diseases observed in DC-STAMP-
deficient mice. On the other hand, diminished produc-
tion of anti-inflammatory cytokine IL-10 could be domi-
nant over the reduction in proinflammatory cytokines.
As IL-10 is crucially involved in preventing excessive
immune responses [43] and plays an important role in
development of suppressor T cells [44,45] decrease in its
production could lead to autoimmune disease.
Conclusions
In conclusion we clearly show the importance of DC-
STAMP expression in cytokines production by mature
mBMDCs. Further studies are necessary to resolve the
pathway by which this phenomenon occurs. We postu-
late that the deregulated cytokines production in DC-
STAMP knock-down mBMDCs upon LPS stimulation is
responsible for impaired T-cell stimulatory capacity of
these cells.
Methods
Cell lines and cell culture
The human embryonic kidney cell line HEK293 was cul-
tured in DMEM (Invitrogen) supplemented with 10%
heat-inactivated FCS (Greiner Bio-One), 1% of non-
essential amino acids (NEAA) (Invitrogen) and 0.5%
antibiotic-antimycotic (Invitrogen). The mouse embryo-
nic fibroblast cell line NIH3T3 was cultured in DMEM
supplemented with 5% heat-inactivated FCS, and 0.5%
antibiotic-antimycotic. HEK293FT cells (Invitrogen)
were cultured in DMEM supplemented with 10% heat-
inactivated FCS, 1% NEAA, 0.5% antibiotic-antimycotic,
1% ultra-glutamine (Lonza), and 1 mM sodium pyruvate
(Invitrogen). Cells were kept under selection with 500
μg/ml of Geneticin (G418) (Invitrogen).
Generation of bone marrow-derived DCs
Mouse BMDCs were generated from bone marrow pro-
genitor cells, according to the modified protocol of Lutz
[46]. Bone marrow cells were flushed from the femurs
and tibias of 6- to 8-week-old female C57BL/6 mice
(Charles River WIGA Gmbh), washed and counted. Cells
were plated at a concentration of 4 × 106 cells per 10 cm
Petri dish in 13 ml of RPMI-1640 medium (Invitrogen)
supplemented with 10% FCS, 1% ultra-glutamine, 28 μM
of b-mercaptoethanol (Sigma-Aldrich), 0.5% antibiotic-
antimycotic and 20 ng/ml of murine recombinant GM-
CSF (PeproTech). After 3 days, 4 ml of fresh medium
was added containing fresh GM-CSF to final concentra-
tion of 8.75 ng/ml. At day 6 non-adherent and loosely
adherent cells were harvested and used for transduction.
Vectors and validation of RNAi
The construction of murine DC-STAMP-GFP vector
was described previously [22]. Four SureSilencing
shRNA plasmids encoding the shRNA sequence target-
ing murine DC-STAMP: shST1 (5’-gctggaagttcactt-
gaaact-3’), shST2 (5’-ttgtggctggaagtatgagaatgt-3’), shST3
(5’-tctggatgatcacctgtgttt-3’), shST4 (5’-ggttcctctcagtat-
tattct-3’) and negative control Scrambled shRNA (shScr)
(5’-ggaatctcattcgatgcatac-3’) plasmid were obtained from
SuperArray Bioscience. In order to validate the silencing
of mDC-STAMP, HEK293 cells were co-transfected
with a plasmid expressing mDC-STAMP-GFP plasmid
and a SureSilencing shRNA plasmid encoding either a
control shRNA or mDC-STAMP-targeting shRNA using
Lipofectamine (Invitrogen) according to the manufac-
turer’s protocol. Forty-eight hours following transfection,
mDC-STAMP-GFP protein levels were determined by
Western blot.
Western blotting
Cells were lysed in 1% SDS buffer and subjected to
Western blot analysis as described previously [22]. GFP-
tagged mDC-STAMP was detected using mouse anti-
GFP antibody (Roche). Actin was detected with a mouse
anti-b-actin Ab (Sigma-Aldrich). Rabbit anti-mouse-
HRP (DakoCytomation) was used as a secondary anti-
body. For detection an ECL Western Blotting Detection
Reagents kit (Amersham Bioscience) and BioMAx XAR
Film (Kodak) were used.
Generation of the lentiviral vector stocks
Using Gateway technology, DNA encoding sequences
for short-hairpin RNAs in the BLOCK-iT-U6-RNAi
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Entry vector were introduced into the pLenti6/BLOCK-
iT-DEST vector (Invitrogen), following the manufac-
turer’s protocol. The individual vectors were co-trans-
fected with packaging vectors into the HEK293FT cells
according to the manufacturer’s instructions. Virus was
produced in HEK293FT culture medium supplemented
with 82.5 μg/ml of water-soluble cholesterol (Sigma-
Aldrich) and collected from tissue culture supernatant
24 and 48 hours after transfection. Cell debris was
removed by centrifugation and supernatant containing
virus particles was filtered through a 0.45 μm filter. Ali-
quots were stored at -80°C until use.
Viral titers were determined by transduction of
NIH3T3 cells with serial dilutions of the virus stock in
the presence of 10 μg/ml of polybrane (Sigma-Aldrich).
Two days after transduction the cells were cultured
under selection with 2 μg/ml of Blasticidin (Invitrogen)
for 12 days. Medium was refreshed every third day. To
determine the titer, the number of colonies was deter-
mined after crystal violet staining. The titer ranged
between 2 × 105 to 13 × 105 transfection units (TU)/ml
Lentiviral knockdown of mDC-STAMP in mBMDCs
Mouse BMDCs were harvested after 6 days of culture
and 1.2 × 106 cells were resuspended in 700 ul of virus
supernatant containing 10 μg/ml of DEAE-dextran
(Pharmacia Biotech AB) to facilitate viral infection. Cell-
virus suspensions were plated on 12-well tissue culture
plates (700 μl/well) and centrifuged for 90 minutes at
2200 rpm and 37°C. After centrifugation, virus superna-
tant was replaced by mBMDC culture medium. The
infection procedure was repeated the following day. As
a negative control, mBMDC culture medium with
DEAE-dextran was used. The multiplicity of infection
(MOI) for silencing of DC-STAMP was matched with
the MOI of the scrambled shRNA control in each
experiment.
RNA isolation and quantitative real-time PCR (qPCR)
Total RNA was isolated from at least 6 × 105 cells using
a Quick-RNA MiniPrep kit (Zymo Research). RNA
quantity and purity were determined using a NanoDrop
spectrophotometer. Two micrograms of total RNA were
treated with DNase-I (Invitrogen) and cDNA was
synthesized using random primers and SuperScript
Moloney murine leukemia virus reverse transcriptase
(II-MMLV) (Invitrogen). Messenger RNA levels for the
genes of interest were determined with a Bio-rad CFX96
(Bio-rad) using Fast Start SYBR Green kit (Roche) and
primers for one of the following genes: porphobilinogen
deaminase (PBGD) (forward: 5’-CCTACCATAC-
TACCTCCTGGCTTTAC-3’; reverse: 5’-
TTTGGGTGAAAGACAACAGCAT-3’), DC-STAMP
(forward: 5’-TTGCCGCTGTGGACTATCTG-3’; reverse:
5’-GAATGCAGCTCGGTTCAAAC-3’), IL-6 (forward:
5’-TGGGAAATCGTGGAAATGAG-3’; reverse: 5’-
CAAGTGCATCATCGTTGTTC-3’), IL-1a (forward: 5’-
CGAAGACTACAGTTCTGCCATT-3’; reverse: 5’-
GACGTTTCAGAGGTTCTCAGAG-3’), IL-1b (forward
5’-GTGATGAGAATGACCTGTTCTTTG-3’; reverse:
5’-GATTTGAAGCTGGATGCTCTC-3’), IL-12p40 (for-
ward 5’-GACACGCCTGAAGAAGATGAC-3’; reverse:
5’-TAGTCCCTTTGGTCCAGTGTG-3’). Data were ana-
lyzed with Bio-rad CFX manager version 1.6 (Bio-rad)
and checked for correct amplification and dissociation
of the products. PBGD served as a reference gene. DC-
STAMP and IL-6 levels relative to PBGD were calcu-
lated as: 2^-(ΔCt).
Cytokine measurements
For cytokine assays, 1 × 105 day 11 mBMDCs were pla-
ted per well on 96-well plate in 200 μl of culture med-
ium. Cells were stimulated with 1 μg/ml of LPS (E. coli,
0111:B4, Sigma-Aldrich). Supernatants were harvested at
the indicated time points and stored at -80°C. Concen-
trations of IL-12p70 and IL-6 in cell culture superna-
tants were measured by ELISA (BD Biosciences),
according to manufacturer’s protocol.
The cytokines and chemokines IL-10, IFN-g, IL-15, IL-
17, IL-1a, IL-1b, IL-2, IL-4, IL-5, IL-7, IL-9, IP-10
(CXCL10), KC (CXCL1), MCP-1 (CCL2), MIP-1a
(CCL3), MIP-2 (CXCL2), RANTES (CCL5), TNF-a and
VEGF in cell culture supernatants were measured using
the mouse cytokine multiplex (Milliplex, Millipore) fol-
lowing the manufacturer’s protocol. Data analysis was
performed using Bio-Plex Manager software (Bio-Rad
Laboratories).
Immunofluorescent staining and Confocal Laser Scanning
Microscopy
Immature mBMDCs (day 11) were seeded onto cover
slides coated with Poly-L-Lysine (Sigma-Aldrich) (5 ×
105 cells/slide), adhered for 2 hours and fixed with 1%
PFA for 15 minutes. Cells were permeabilized with
methanol (-20°C; 1 min) and blocked with 3% BSA (Cal-
biochem) in 1 × PBS supplemented with 0.1% saponin
(Sigma-Aldrich). Rabbit anti-calreticulin (Calbiochem)
antibody was used to visualize ER. As an isotype control,
purified rabbit IgG (Sigma-Aldrich) was used. As a sec-
ondary antibody, goat anti-rabbit-Alexa488 (BD Bios-
ciences) was used. The nucleus was stained with DAPI.
Slides were mounted in Mowiol (Calbiochem) and ana-
lyzed by CLSM using an Olympus FV1000.
Mixed lymphocyte reactions
Mixed lymphocyte reactions (MLRs) were performed
using day 12 C57BL/6 mBMDCs as stimulators. Spleno-
cytes from Balb/c mice (Harlan) depleted for B220-
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positive cells were used as responders. Negative selec-
tion for B220-positive cells was performed to increase T
cell numbers in the splenocyte pool. Briefly, splenocytes
were stained with an anti-B220-FITC antibody (BioLe-
gend) then incubated with magnetic beads coupled to
anti-FITC antibodies and purified with a magnetic bead-
based kit (MACS; Miltenyi-Biotec). Cells were labeled
with 1 μM CFSE (Invitrogen) at a concentration of 50 ×
106 B220-negative cells/ml for 7 min at 37°C in PBS
with 1% FCS. MLR assays were carried out in 96-well
round-bottom plates (200 μl/well) at a ratio of 1:2 or 1:3
(responders to stimulators), for 4 to 5 days in T cell
medium (IMDM (Invitrogen) containing 10% FCS, 1%
antibiotic-antimycotic, 0.5% ultra-glutamine, 28 μM of
b-mercaptoethanol and 60 IU of human IL-2 (Proleukin;
Chiron BV, Amsterdam, The Netherlands). The prolif-
eration rate was assessed by FACS analysis of CFSE
dilution.
Flow cytometry
For cell surface labeling, the following anti-mouse anti-
bodies were used (from BD Biosciences, unless stated
differently): PE-conjugated anti-CD86 (GL1), anti-CD80
(16-10A1), anti-CD40 (3/23), anti-CD8a (53-6.7), anti-
MHC class II (M5/114.15.2, eBioscience); PerCP-conju-
gated anti-CD62L (Mel-14, BioLegend); APC-conjugated
anti-CD11c (N418, BioLegend); APCCy7-conjugated
anti-CD4 (L3T4). Flow cytometry was performed using
a CyAn flow cytometer (Beckman Coulter) and analyzed
with FlowJo software (TreeStar).
Statistical analysis
Statistical significance was calculated using a two-tailed
Student t test (GraphPad Prism version 4.00 software).
Data obtained from ELISA and Milliplex experiments
were log2-transformed before statistical analysis. Signifi-
cance of difference was determined by the p value (*p <
0.05; **p < 0.01; ***p < 0.001).
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